These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 23974620)

  • 21. Basics of compounding: implementing United States pharmacopeia chapter <795> pharmaceutical compounding--nonsterile preparations, part 4.
    Allen LV
    Int J Pharm Compd; 2012; 16(1):64-8. PubMed ID: 23050315
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A collaborative effort to comply with USP chapter 797 for compounding sterile preparations for investigational use.
    Formea CM; Weiss WT; McCluskey SV
    Am J Health Syst Pharm; 2008 Jul; 65(13):1266-9. PubMed ID: 18574018
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Quality-control standard operating procedures-an essential tool for developing quality preparations.
    Ashworth LD
    Int J Pharm Compd; 2007; 11(3):226-8. PubMed ID: 23996025
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Development of a standardized Intranet database of formulation records for nonsterile compounding, Part 2.
    Haile M; Anderson K; Evans A; Crawford A
    Int J Pharm Compd; 2012; 16(2):104-9. PubMed ID: 23050321
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Survey of sterile admixture practices in canadian hospital pharmacies: part 2. More results and discussion.
    Warner T; Nishi C; Checkowski R; Hall KW
    Can J Hosp Pharm; 2009 May; 62(3):192-203. PubMed ID: 22478890
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Survey of sterile admixture practices in canadian hospital pharmacies: part 1. Methods and results.
    Warner T; Nishi C; Checkowski R; Hall KW
    Can J Hosp Pharm; 2009 Mar; 62(2):100-11. PubMed ID: 22478875
    [TBL] [Abstract][Full Text] [Related]  

  • 27. End-preparation assessments and tests for compounded sterile preparations.
    McElhiney LF
    Int J Pharm Compd; 2013; 17(4):307-11. PubMed ID: 24261146
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Quality-control analytical methods: a guide to quality control testing for the compounding pharmacist.
    Zolner WJ
    Int J Pharm Compd; 2006; 10(4):281-2. PubMed ID: 23974260
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Current Landscape of Veterinary Compounding in the Pharmacy Setting.
    Gochenauer AE; Holmes ER; Barber KE; Forsythe LR
    Int J Pharm Compd; 2019; 23(5):422-427. PubMed ID: 31513542
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Compounding parenteral nutrition: reducing the risks.
    Curtis C; Sacks GS
    Nutr Clin Pract; 2009; 24(4):441-6. PubMed ID: 19605798
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Obtaining accreditation by the pharmacy compounding accreditation board, part 4: tips for "last minute" preparations.
    Cabaleiro J
    Int J Pharm Compd; 2008; 12(5):432-3. PubMed ID: 23969868
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Quality-Control Analytical Methods: Microbial-Testing Aspects of USP Chapter 797 for Compounded Sterile Preparations.
    Kupiec TC
    Int J Pharm Compd; 2005; 9(1):47-9. PubMed ID: 23924865
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Survey of sterile product compounding practices in Canadian hospital pharmacies.
    Fitch DP; Hall KW
    Can J Hosp Pharm; 1993 Dec; 46(6):249-60. PubMed ID: 10131343
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacists' documentation in patients' hospital health records: issues and educational implications.
    Pullinger W; Franklin BD
    Int J Pharm Pract; 2010 Apr; 18(2):108-15. PubMed ID: 20441120
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Basics of compounding: the responsibilities of compounding personnel in implementing United States pharmacopeia chapter 797 pharmaceutical compounding-sterile preparations, part 2.
    Allen LV; Okeke CC
    Int J Pharm Compd; 2007; 11(4):313-23. PubMed ID: 23974791
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Basics of compounding: considerations for implementing United States pharmacopeia chapter 797 pharmaceutical compounding-sterile preparations, part 8: stability and beyond-use dating.
    Allen LV; Okeke CC
    Int J Pharm Compd; 2008; 12(4):344-53. PubMed ID: 23969772
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Outbreak of bacteremia due to Burkholderia contaminans linked to intravenous fentanyl from an institutional compounding pharmacy.
    Moehring RW; Lewis SS; Isaacs PJ; Schell WA; Thomann WR; Althaus MM; Hazen KC; Dicks KV; Lipuma JJ; Chen LF; Sexton DJ
    JAMA Intern Med; 2014 Apr; 174(4):606-12. PubMed ID: 24493147
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Development of a standardized intranet database of formulation records for nonsterile compounding, part 1.
    Evans A; Haile M; Anderson K
    Int J Pharm Compd; 2010; 14(5):401-5. PubMed ID: 23965584
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A needle-free reconstitution and transfer system for compounded sterile intravenous drug solutions in compliance with United States Pharmacopeia Chapter <797> standards.
    Marks Z
    Int J Pharm Compd; 2014; 18(2):94-9. PubMed ID: 24881111
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Extemporaneous Compounding: Selective Pharmacists with Separate Skill.
    Mohiuddin AK
    Innov Pharm; 2019; 10(4):. PubMed ID: 34007590
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.